Does fish oil supplementation increase cholesterol efflux capacity in familial hypercholesterolaemia?
Eur J Clin Invest
.
2023 Oct;53(10):e14048.
doi: 10.1111/eci.14048.
Epub 2023 Jun 29.
Authors
Dick C Chan
1
,
Annalisa Ronca
2
,
Qidi Ying
1
,
Jing Pang
1
,
Mikaël Croyal
3
4
5
,
Gerald F Watts
1
6
,
Elda Favari
2
Affiliations
1
Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
2
Department of Food and Drug, University of Parma, Parma, Italy.
3
Nantes Université, CNRS, INSERM, l'institut du thorax, Nantes, France.
4
Nantes Université, CHU Nantes, Inserm, CNRS, SFR Santé, Inserm UMS 016, Nantes, France.
5
CRNH-Ouest Mass Spectrometry Core Facility, Nantes, France.
6
Lipid Disorders Clinic, Department of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, Western Australia, Australia.
PMID:
37386840
PMCID:
PMC10909456
DOI:
10.1111/eci.14048
No abstract available
Publication types
Letter
MeSH terms
Cholesterol, HDL
Cholesterol, LDL
Dietary Supplements
Fish Oils*
Humans
Hyperlipoproteinemia Type II* / drug therapy
Substances
Fish Oils
Cholesterol, LDL
Cholesterol, HDL
Grants and funding
1028883/NHMRC